Selene Therapeutics is a biotechnology startup, founded in 2020, specializing in innovative small molecule inhibitors targeting mitochondrial enzymes to address refractory epilepsy. The company's unique approach aims to reduce neuronal firing rates to mitigate this condition. Specifically, Selene is focused on creating small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a critical mitochondrial enzyme involved in essential cellular homeostatic processes. The company received its Seed Round investment on 01 October 2020 with backing from RMGP and FutuRx. Their ambitious mission and promising technology make Selene Therapeutics a compelling player in the biotechnology and health and wellness sectors.
Selene Therapeutics
Innovative small molecule inhibitors targeting mitochondrial enzymes to address refractory epilepsy by reducing neuronal firing rates
Founded 2020
2-10 employees
Seed
Biotechnology, Health and Wellness
General Information
Company Name
Selene Therapeutics
Founded Year
2020
Founders / Decision Makers
Employees
2-10
Industries
Biotechnology, Health and Wellness
Funding Stage
Seed
Social
BounceWatch is an independent company data service, not affiliated with Selene Therapeutics. To contact Selene Therapeutics, visit selenetx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Selene Therapeutics compare?
A PDF of Selene Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Selene Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Selene Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Selene Therapeutics
Business keywords: Selene Therapeutics, small molecule inhibitors, DHODH, mitochondrial enzymes, refractory epilepsy, neuronal firing rates, neuronal activity modulation, therapeutic approach, cellular homeostasis, neuronal mean firing rate, regulation of neuronal activity, innovative therapies, biotech startups, drug development, neurological disorders
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 2 |
|
01 Oct 2020 |
Selene Therapeutics Alternatives & Competitors
View All Alternatives
Selene Therapeutics vs
Pioneering the development and commercialization of therapeutic inhibitors to combat hyperplasia and...
Debt Financing
2-10 employees
Biotechnology, Health Care
Selene Therapeutics vs
Asceneuron SA
Switzerland
Targeting the root cause of neurodegeneration
Series C
20 employees
Biotechnology, Health Care
Selene Therapeutics vs
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient outcomes in c...
Series B
2-10 employees
Biotechnology, Health Care
FAQ About Selene Therapeutics
Innovative small molecule inhibitors targeting mitochondrial enzymes to address refractory epilepsy by reducing neuronal firing rates
Selene Therapeutics was founded in 2020.
Selene Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on Selene Therapeutics, small molecule inhibitors, DHODH and mitochondrial enzymes.
Selene Therapeutics has approximately 2-10 employees.
Selene Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Selene Therapeutics include Corridor Pharmaceuticals, Inc., Asceneuron SA, Pinteon Therapeutics, Rgenta Therapeutics Inc., Petra Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Selene Therapeutics and Corridor Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Selene Therapeutics, https://bouncewatch.com/company/selene-therapeutics, updated 2 January 2025. When citing, please name BounceWatch and link this page.
